|
ATOS Atossa Therapeutics Inc 1488039 |
| Balance Sheet |
|
Current Assets
|
77,111,000 |
|
Assets
|
79,477,000 |
|
Current Liabilities
|
5,796,000 |
|
Liabilities
|
5,796,000 |
|
Equity
|
73,681,000 |
|
Shares Out
|
125,757,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-13,979,000 |
|
Investing Cash Flow
|
-19,000 |
| Market Analysis |
Market Cap
|
184,234,595 |
|
Price
|
0.72 |
|
BVPS
|
0.59 |
|
PB
|
1.26 |
|
EPS
|
-0.21 |
|
PS
|
69.20 |
|
FCF
|
-13,998,000 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/01 |
|
5/13 |
-0.05 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ATOS documents filed with the SEC.
ATOS Filings
Clear
